There is an interesting shift happening in healthcare’s digital transformation efforts. We are no longer simply using software to support clinicians; we are operating within a software-defined clinical environment. Today, clinical workflows, revenue cycles, patient engagement platforms, analytics pipelines, and AI models run on shared digital infrastructure affecting key care outcomes. A radiology model, for example, is not just producing an image; it is feeding clinical decision engines, influencing billing documentation, etc.
As these tools become more intelligent and autonomous, a new problem has surfaced. Healthcare organizations are struggling to keep track of how they actually behave in real time. Interactions between data pipelines, user decisions, and infrastructure conditions have created dependencies that are often invisible in aggregate. As this black-box logic – where the internal workings of the system remain hidden – finds its way into high-stakes clinical and operational workflows, it creates new, invisible risks.
Why Point-in-Time Governance Is Already Obsolete
Healthcare governance mechanisms are still structured around periodic review: audit cycles, committee oversight, pre-deployment assessments, retrospective safety analysis, quarterly financial reviews, etc. This approach made sense when software behaved predictably and defined inputs produced consistent outputs.
AI changes this dynamic. Risk no longer concentrates in single deployment decisions; rather, it accumulates in system behavior over time and does not trigger the obvious alarms. A triage algorithm or predictive sepsis model, for example aren’t static asset that can be certified once and left alone. They behave more like an ongoing participant in care delivery and experience performance drift as patient populations change, workflows evolve, or upstream systems are modified.
When governance is periodic, but systems are continuous, risk slips in through the gaps. Let’s say a routine EHR update introduced a drift in a model. The precision drop will not be immediate. There might be a small percentage dip over a few months. By the time a quarterly review catches it, the accumulated exposure may already be affecting clinical decisions and patient safety. These issues also lead to a loss of trust in the system and affect clinic adoption.
This gap needs a control pane and that’s where observability comes in. It addresses this structural mismatch by making system behavior visible in real time across infrastructure through continuous monitoring of data, models, and user interactions.
From Monitoring to Observability
In IT environments, observability emerged when distributed systems became too complex for surface monitoring. Logs, metrics, and traces used to answer a simple question – what is happening inside the system right now, and why? However, with AI in the picture, and in a regulated industry like healthcare, the stakes are higher than just system uptime. We don’t just need to know if the AI is running; we need to know if the AI is “reasoning” correctly -by leveraging the context of the clinical workflow.
Which is why observability must extend beyond logs to answer questions like:
- Why was a specific treatment recommended?
- Why did care quality metrics degrade after a workflow change?
- Why did cloud costs spike?
- Why did sensitive data flow into an unauthorized system have?
Basically, if traditional monitoring tells you the car stopped, observability explains what led up to it – a drifting sensor, an imbalanced fuel mix, or something else.
The Four Pillars of the AI Control Infrastructure
To matter at the executive decision level, observability cannot live in the IT domain alone. It must be integrated into the strategic reporting of the organization across four distinct layers:
A. The Data Provenance Layer
Regulatory frameworks like the NIST AI Risk Management Framework (RMF) and emerging HHS mandates are moving toward a requirement for traceability.
If a patient suffers an adverse event where an AI was involved, the organization must be able to produce an immutable audit trail:
- What version of the model was running?
- What specific data inputs did it receive?
- What exact outputs did it deliver and in what form?
- What was the “confidence score” of its output?
- Which clinician saw the output, and how did they react? Is there a record of the clinician using/accepting the output in their clinical decision-making?
Without an observability infrastructure, reconstructing this timeline is nearly impossible. As data moves across platforms, vendors, Shadow AI, and internal teams, observability can provide its lineage. Where did this PHI (Protected Health Information) originate? Which model processed it? Did it cross a regulatory boundary it shouldn’t have? Where was the data privacy policy not applied or overlooked? This traceability helps demonstrate how compliance is maintained continuously.
B. The Model Integrity Layer
Pre-trained machine learning models are optimized on their training datasets. Drift occurs when live data diverges from training data. A new clinic opening in a different zip code can shift population characteristics enough to reduce the accuracy of a readmission predictor for that location.
Observability surfaces these localized performance changes early. It allows teams to detect subgroup degradation, flag anomalies, and escalate to human review before small deviations turn into systemic issues. When it comes to foundation models such as the SOTA large language models (LLMs), training or retraining them again is not possible or practical. In that case, grounding LLMs with proper context and applying guardrails for it to stay within the contextual boundaries is of utmost importance. Performance evaluation and continuous monitoring of such models require different evaluation frameworks and metrics than traditional ML models.
C. The Workflow & Trust Layer
Trust in AI is fragile. When an AI tool provides an incorrect output, clinicians start to disengage and begin to override the system. On the other hand, too much trust might lead to “cognitive surrender” and have grave consequences of acting on incorrect recommendations. Both situations are undesirable in the healthcare context. With observability mechanisms in place, organizations can track these behavioral signals in real time and take corrective action.
D. The Economic & Compute Layer
AI is expensive and the inference cost, particularly with large models running across multiple departments, can spiral if not monitored. For the CFO, observability connects the dots between compute usage and clinical value. It helps the organization identify redundant models, vendor sprawl, and Ghost AI tools that are consuming resources without contributing to the margin. This visibility enables rationalization decisions grounded in both performance and economics.
An Executive Framework for Healthcare Observability
For boards and CIOs, observability belongs alongside cybersecurity and enterprise data governance. It shapes how AI risk is identified, measured, and managed.
Practical implementation requires:
- Treating observability as non-negotiable core infrastructure, not just tooling.
- Ensuring visibility from data ingestion through model behavior to clinician interaction and final outcomes
- Defining thresholds aligned to patient safety, regulatory exposure, compliance, privacy obligations, and financial sustainability.
- Connecting those thresholds to automated response paths — review, pause, or escalate.
- Designing for scale early to avoid fragmented controls later.
This creates disciplined AI growth, sustained leadership visibility, and manageable financial exposure as deployments expand.
Control as a Catalyst for Speed
The common misconception is that governance slows things down. In reality, the opposite is true. While it takes upfront investment and commitments to design and implement governance controls, it pays dividends in the long run.
In healthcare, the organizations that will win the AI Race are not those who deploy the most models, but those who can manage the most models at scale without losing institutional control. When you have a control pane for trust, you can move faster, innovate more aggressively, de-risk, and scale with the confidence that the system is behaving exactly as intended.
The next phase of healthcare is not just AI-led; it is observability-governed. For the modern CXO, this isn’t just a technical requirement; it is the foundation of the architecture of accountability.
About Kaushik Raha
Kaushik Raha, PhD, Vice President, CitiusTech leads the development and deployment of AI-driven innovations for healthcare and life sciences. With more than two decades of experience spanning healthcare, pharmaceuticals, clinical research, and health information services, he has held leadership roles at CitiusTech, Elsevier, Johnson & Johnson, and GSK. Trained as a scientist with advanced degrees from AIIMS, Penn State University, and UCSF, Kaushik brings a rare blend of deep scientific expertise and practical AI leadership, helping organizations translate emerging technologies into measurable healthcare outcomes.
